KMT2A and acute myeloid leukemia: The in vitro deletion of Atg5 transiently decreased the colony-forming capacity of BM cells expressing MLL-AF9, consistent with in vivo data where Atg5 deletion significantly delayed MLL-AF9-induced AML initiation.